Literature DB >> 22349614

CD5 expression promotes multiple intracellular signaling pathways in B lymphocyte.

Rizgar A Mageed1, Soizic Garaud, Taher E Taher, Kaushal Parikh, Jacques-Olivier Pers, Christophe Jamin, Yves Renaudineau, Pierre Youinou.   

Abstract

CD5(+) B lymphocytes have distinct functional properties compared with B lymphocytes that lack CD5. However, it remains unclear if and how the CD5 molecule modulates B lymphocyte biology and responses. Our recent studies have revealed that CD5 promotes constitutive activation of multiple signaling pathways including extracellular signal-regulated kinases (ERK1/2), phosphatidylinositol 3-kinase (PI-3K)/mammalian target of rapamycin (mTOR) and calcineurin-NFAT signaling pathways. Further, changes in cytokine production including the production of IL-10 are related to the activation of the transcription factors NFAT2 and STAT3. All in all, these studies provide a framework for understanding how CD5 impacts B lymphocyte biology and responses.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22349614     DOI: 10.1016/j.autrev.2012.02.007

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  17 in total

1.  Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Sebastian Unizony; Noha Lim; Deborah J Phippard; Vincent J Carey; Eli M Miloslavsky; Nadia K Tchao; David Iklé; Adam L Asare; Peter A Merkel; Paul A Monach; Philip Seo; E William St Clair; Carol A Langford; Robert Spiera; Gary S Hoffman; Cees G M Kallenberg; Ulrich Specks; John H Stone
Journal:  Arthritis Rheumatol       Date:  2015-02       Impact factor: 10.995

Review 2.  Innate B Cells: the Archetype of Protective Immune Cells.

Authors:  Alexis Grasseau; Marina Boudigou; Laëtitia Le Pottier; Nedra Chriti; Divi Cornec; Jacques-Olivier Pers; Yves Renaudineau; Sophie Hillion
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

3.  HIV, Cytomegalovirus, and Malaria Infections during Pregnancy Lead to Inflammation and Shifts in Memory B Cell Subsets in Kenyan Neonates.

Authors:  Kee Thai Yeo; Paula Embury; Timothy Anderson; Peter Mungai; Indu Malhotra; Christopher King; James Kazura; Arlene Dent
Journal:  J Immunol       Date:  2019-01-23       Impact factor: 5.422

Review 4.  Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus.

Authors:  Aurélie De Groof; Patrice Hémon; Olivier Mignen; Jacques-Olivier Pers; Edward K Wakeland; Yves Renaudineau; Bernard R Lauwerys
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

Review 5.  A Review of Autoimmune Disease Hypotheses with Introduction of the "Nucleolus" Hypothesis.

Authors:  Wesley H Brooks
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

6.  Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment Responders.

Authors:  Diana Ahmetspahic; Kathrin Schwarte; Oliver Ambrée; Christian Bürger; Vladislava Falcone; Katharina Seiler; Mehrdad Rahbar Kooybaran; Laura Grosse; Fernand Roos; Julia Scheffer; Silke Jörgens; Katja Koelkebeck; Udo Dannlowski; Volker Arolt; Stefanie Scheu; Judith Alferink
Journal:  J Neuroimmune Pharmacol       Date:  2017-09-13       Impact factor: 4.147

Review 7.  Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up.

Authors:  Laurent Simonin; Elisabeth Pasquier; Christophe Leroyer; Divi Cornec; Julie Lemerle; Boutahar Bendaoud; Sophie Hillion; Jacques-Olivier Pers; Francis Couturaud; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

8.  Increased CD5-positive polyclonal B cells in Castleman disease: a diagnostic pitfall.

Authors:  Qingyan Liu; Stefania Pittaluga; Theresa Davies-Hill; Mark Raffeld; Liqiang Xi; Elaine S Jaffe
Journal:  Histopathology       Date:  2013-08-19       Impact factor: 5.087

9.  Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).

Authors:  Christelle Le Dantec; Ruby Alonso; Tinhinane Fali; Enrique Montero; Valérie Devauchelle; Alain Saraux; Jacques-Olivier Pers; Yves Renaudineau
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 10.  Human endogenous retrovirus group E and its involvement in diseases.

Authors:  Christelle Le Dantec; Sophie Vallet; Wesley H Brooks; Yves Renaudineau
Journal:  Viruses       Date:  2015-03-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.